The DOI matches its Crossref record; 123 of the 123 references it cites were found in a registry or an index.
Neurosteroids: endogenous regulators of the GABAA receptor
Abstract
GABA(A) (gamma-aminobutyric acid type A) receptors mediate most of the 'fast' synaptic inhibition in the mammalian brain and are targeted by many clinically important drugs. Certain naturally occurring pregnane steroids can potently and specifically enhance GABA(A) receptor function in a nongenomic (direct) manner, and consequently have anxiolytic, analgesic, anticonvulsant, sedative, hypnotic and anaesthetic properties. These steroids not only act as remote endocrine messengers, but also can be synthesized in the brain, where they modify neuronal activity locally by modulating GABA(A) receptor function. Such 'neurosteroids' can influence mood and behaviour in various physiological and pathophysiological situations, and might contribute to the behavioural effects of psychoactive drugs.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Allopregnanolone is a potent allosteric modulator of GABAA, while 5α-pregnane-3α,20α-diol is less neuroactive”
From Role of aldo-keto reductase family 1 (AKR1) enzymes in human steroid metabolism (2014) · cites this paper as [42]
Citations
Cites
International Union of Pharmacology: Approaches to the Nomenclature of Voltage-Gated Ion Channels
Catterall, W. A., Chandy, K. G., Clapham, D. E., Gutman, G. A., Hofmann, F., Harmar, A. J., Abernethy, D. R., & Spedding, M. (2003) · Pharmacological Reviews · doi:10.1124/pr.55.4.5 · Cited by 7,126
Excitatory actions of gaba during development: the nature of the nurture
Ben-Ari, Y. (2002) · Nature Reviews Neuroscience · doi:10.1038/nrn920 · Cited by 2,448
Variations on an inhibitory theme: phasic and tonic activation of GABAA receptors
Farrant, M., & Nusser, Z. (2005) · Nature Reviews Neuroscience · doi:10.1038/nrn1625 · Cited by 2,081
Paul, S. M., & Purdy, R. H. (1992) · The FASEB Journal · doi:10.1096/fasebj.6.6.1347506 · Cited by 1,413
Barnard, E. A., Skolnick, P., Olsen, R. W., Möhler, H., Sieghart, W., Biggio, G., Bræstrup, C., Bateson, A. N., & Langer, S. Z. (1998) · PubMed · Cited by 1,204
Is there more to gaba than synaptic inhibition?
Owens, D. F., & Kriegstein, A. R. (2002) · Nature reviews. Neuroscience · doi:10.1038/nrn919 · Cited by 1,172
Receptor trafficking and synaptic plasticity
Collingridge, G. L., Isaac, J. T. R., & Wang, Y. T. (2004) · Nature Reviews Neuroscience · doi:10.1038/nrn1556 · Cited by 1,046
Purdy, R. H., Morrow, A. L., Moore, P. H., & Paul, S. M. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.10.4553 · Cited by 951
Subunit Composition, Distribution and Function of GABA-A Receptor Subtypes
Sieghart, W., & Sperk, G. (2002) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026023393507 · Cited by 914
Stell, B. M., Brickley, S. G., Tang, C., Farrant, M., & Módy, I. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2435457100 · Cited by 799
Research works printed but not linked: 4
- Melcangi, R. C., Magnaghi, V., Galbiati, M. & Martini, L. in Neurosteroid and Brain Function (eds Biggio, G. & Purdy, R. H.) 146–176 (Academic, San Diego, 2001).
- Sundstrom-Poromaa, I. in Neurosteroid Effects in the Central Nervous System: the Role of the GABAA Receptor (ed. Smith, S. S.) 291–304 (CRC, New York, 2004).
- Mtchedlishvili, Z. & Kapur, J. in Neurosteroid Effects in the Central Nervous System: the Role of the GABAA Receptor (ed. Smith, S. S.) 305–316 (CRC, New York, 2004).
- Gibbs, T. T. & Farb, D. H. in Neurosteroid Effects in the Central Nervous System: the Role of the GABAA Receptor (ed. Smith S. S.) 339–358 (CRC, New York, 2004).
Cited by
Sorted by citations
Rupprecht, R., Papadopoulos, V., Rammes, G., Baghai, T. C., Fan, J., Akula, N., Groyer, G., Adams, D., & Schumacher, M. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3295 · Cited by 930
Structure, Function, and Modulation of GABAA Receptors
Sigel, E., & Steinmann, M. E. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.r112.386664 · Cited by 819
Endogenous neurosteroids regulate GABAA receptors through two discrete transmembrane sites
Hosie, A. M., Wilkins, M. E., da Silva, H. M. A., & Smart, T. G. (2006) · Nature · doi:10.1038/nature05324 · Cited by 752
Crystal structure of a human GABAA receptor
Miller, P. S., & Aricescu, A. R. (2014) · Nature · doi:10.1038/nature13293 · Cited by 734
Extrasynaptic GABAA Receptors: Their Function in the CNS and Implications for Disease
Brickley, S. G., & Módy, I. (2012) · Neuron · doi:10.1016/j.neuron.2011.12.012 · Cited by 695
GABAA receptor trafficking and its role in the dynamic modulation of neuronal inhibition
Jacob, T. C., Moss, S. J., & Jurd, R. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2370 · Cited by 695
Millan, M. J. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.11.006 · Cited by 569
Role of GABA in anxiety and depression
Kalueff, A. V., & Nutt, D. (2006) · Depression and Anxiety · doi:10.1002/da.20262 · Cited by 563
GABA-based therapeutic approaches: GABAA receptor subtype functions
RUDOLPH, U., & MOHLER, H. (2006) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2005.10.003 · Cited by 499
The neuroprotective actions of oestradiol and oestrogen receptors
Arévalo, M., Azcoitia, Í., & García‐Segura, L. M. (2014) · Nature reviews. Neuroscience · doi:10.1038/nrn3856 · Cited by 478
Extrasynaptic GABA A Receptors: Form, Pharmacology, and Function
Belelli, D., Harrison, N. L., Maguire, J., Macdonald, R. L., Walker, M. C., & Cope, D. W. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.3340-09.2009 · Cited by 464
“Neuron-selective actions of neurosteroids at synaptic and extrasynaptic GABAARs Neurosteroids, typified by the progesterone metabolite allopregnanolone, potently modulate neuronal excitability through endocrine, paracrine, or autocrine actions at GABAARs (Belelli and Lambert, 2005).”
BackgroundInfluentialSelf-citationCHARMM-GUI supports the Amber force fields
Lee, J., Hitzenberger, M., Rieger, M., Kern, N. R., Zacharias, M., & Im, W. (2020) · The Journal of Chemical Physics · doi:10.1063/5.0012280 · Cited by 447
GABAA receptors: structure, function, pharmacology, and related disorders
Ghit, A., Assal, D., Al‐Shami, A. S., & Hussein, D. E. E. (2021) · Journal of Genetic Engineering and Biotechnology · doi:10.1186/s43141-021-00224-0 · Cited by 456
Gonadal steroid hormones and the hypothalamo–pituitary–adrenal axis
Handa, R. J., & Weiser, M. J. (2014) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2013.11.001 · Cited by 408
Mony, L., Kew, J. N. C., Gunthorpe, M. J., & Paoletti, P. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00304.x · Cited by 420
Transient receptor potential M3 channels are ionotropic steroid receptors in pancreatic β cells
Wagner, T. F. J., Loch, S., Lambert, S., Straub, I., Mannebach, S., Mathar, I., Düfer, M., Lis, A., Flockerzi, V., Philipp, S. E., et al. (2008) · Nature Cell Biology · doi:10.1038/ncb1801 · Cited by 392
Characterization of brain neurons that express enzymes mediating neurosteroid biosynthesis
Agís‐Balboa, R. C., Pinna, G., Zhubi, A., Maloku, E., Veldić, M., Costa, E., & Guidotti, A. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0606544103 · Cited by 384
Fast Synaptic Inhibition in Spinal Sensory Processing and Pain Control
Zeilhofer, H. U., Wildner, H., & Yévenes, G. E. (2012) · Physiological Reviews · doi:10.1152/physrev.00043.2010 · Cited by 394
GABAA receptor diversity and pharmacology
Möhler, H. (2006) · Cell and Tissue Research · doi:10.1007/s00441-006-0284-3 · Cited by 368
Activation of GABAA Receptors: Views from Outside the Synaptic Cleft
Glykys, J., & Mody, I. (2007) · Neuron · doi:10.1016/j.neuron.2007.11.002 · Cited by 358
GABAA receptor: Positive and negative allosteric modulators
Olsen, R. W. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2018.01.036 · Cited by 369
do Rego, J. L., Seong, J. Y., Burel, D., Leprince, J., Luu-The, V., Tsutsui, K., Tonon, M., Pelletier, G., & Vaudry, H. (2009) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2009.05.006 · Cited by 365
Schumacher, M., Mattern, C., Ghoumari, A. M., Oudinet, J., Lière, P., Labombarda, F., Sitruk-Ware, R. L., Nicola, A. F. D., & Guennoun, R. (2013) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2013.09.004 · Cited by 368
Tumors induce de novo steroid biosynthesis in T cells to evade immunity
Mahata, B., Pramanik, J., van der Weyden, L., Polański, K., Kar, G., Riedel, A., Chen, X. X., Fonseca, N. A., Kundu, K., Campos, L. S., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-17339-6 · Cited by 333
Translocator protein (18 kD) as target for anxiolytics without benzodiazepine-like side effects
Rupprecht, R., Rammes, G., Eser, D., Baghai, T. C., Schüle, C., Nothdurfter, C., Troxler, T., Gentsch, C., Kalkman, H. O., Chaperon, F., et al. (2009) · Science · doi:10.1126/science.1175055 · Cited by 328
Structure, Pharmacology, and Function of GABAA Receptor Subtypes
Sieghart, W. (2006) · Advances in pharmacology · doi:10.1016/s1054-3589(06)54010-4 · Cited by 321
Rudolph, U., & Möhler, H. (2014) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-011613-135947 · Cited by 319
Neurosteroids as novel antidepressants and anxiolytics: GABA-A receptors and beyond
Zorumski, C. F., Paul, S. M., Covey, D. F., & Mennerick, S. (2019) · Neurobiology of Stress · doi:10.1016/j.ynstr.2019.100196 · Cited by 305
Binding, activation and modulation of Cys-loop receptors
Miller, P. S., & Smart, T. G. (2010) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2009.12.005 · Cited by 306
The bile acid receptor TGR5 (Gpbar-1) acts as a neurosteroid receptor in brain
Keitel, V., Görg, B., Bidmon, H. J., Zemtsova, I., Spomer, L., Zilles, K., & Häussinger, D. (2010) · Glia · doi:10.1002/glia.21049 · Cited by 274
Paul, S. M., Doherty, J., Robichaud, A. J., Belfort, G. M., Chow, B. Y., Hammond, R., Crawford, D. C., Linsenbardt, A. J., Shu, H., Izumi, Y., et al. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.2619-13.2013 · Cited by 276
Brain cholesterol turnover required for geranylgeraniol production and learning in mice
Kotti, T. J., Ramirez, D. M. O., Pfeiffer, B. E., Huber, K. M., & Russell, D. W. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0600316103 · Cited by 270
Pibiri, F., Nelson, M., Guidotti, A., Costa, E., & Pinna, G. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0801853105 · Cited by 261
Extrasynaptic GABA A Receptors of Thalamocortical Neurons: A Molecular Target for Hypnotics
Belelli, D., Peden, D. R., Rosahl, T. W., Wafford, K. A., & Lambert, J. J. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.2679-05.2005 · Cited by 252
Self-citationCarver, C. M., & Reddy, D. S. (2013) · Psychopharmacology · doi:10.1007/s00213-013-3276-5 · Cited by 257
Pinna, G., Costa, E., & Guidotti, A. (2006) · Psychopharmacology · doi:10.1007/s00213-005-0213-2 · Cited by 245
Maguire, J. L., & Módy, I. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.4945-06.2007 · Cited by 244
Membrane Protein Structure, Function, and Dynamics: a Perspective from Experiments and Theory
Cournia, Z., Allen, T. W., Andricioaei, I., Antonny, B., Baum, D., Brannigan, G., Buchete, N.-V., Deckman, J. T., Delemotte, L., del Val, C., et al. (2015) · The Journal of Membrane Biology · doi:10.1007/s00232-015-9802-0 · Cited by 235
Neuroactive steroids: State of the art and new perspectives
Melcangi, R. C., García‐Segura, L. M., & Mensah‐Nyagan, A. G. (2007) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-007-7403-5 · Cited by 249
The Influence of Gonadal Hormones on Neuronal Excitability, Seizures, and Epilepsy in the Female
Scharfman, H. E., & MacLusky, N. J. (2006) · Epilepsia · doi:10.1111/j.1528-1167.2006.00672.x · Cited by 238
Novel mechanisms for neuroendocrine regulation of aggression
Soma, K. K., Scotti, M. L., Newman, A. E. M., Charlier, T. D., & Demas, G. E. (2008) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2007.12.003 · Cited by 236
Regulation of anxiety during the postpartum period
Lonstein, J. S. (2007) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2007.05.002 · Cited by 242
Guennoun, R., Labombarda, F., Deniselle, M. C. G., Lière, P., Nicola, A. F. D., & Schumacher, M. (2014) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2014.09.001 · Cited by 232
Lieberman, J. A., Bymaster, F. P., Meltzer, H. Y., Deutch, A. Y., Duncan, G. E., Marx, C. E., Aprille, J. R., Dwyer, D. S., Li, X., Mahadik, S. P., et al. (2008) · Pharmacological Reviews · doi:10.1124/pr.107.00107 · Cited by 225
Brunton, P. J. (2013) · Reproduction · doi:10.1530/rep-13-0258 · Cited by 219
Non-genomic progesterone actions in female reproduction
Gellersen, B., Fernandes, M. S., & Brosens, J. J. (2008) · Human Reproduction Update · doi:10.1093/humupd/dmn044 · Cited by 221
Progesterone Synthesis in the Nervous System: Implications for Myelination and Myelin Repair
Schumacher, M., Hussain, R., Gago, N., Oudinet, J., Mattern, C., & Ghoumari, A. M. (2012) · Frontiers in Neuroscience · doi:10.3389/fnins.2012.00010 · Cited by 233
Neurosteroid binding sites on GABAA receptors
Hosie, A. M., Wilkins, M. E., & Smart, T. G. (2007) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2007.03.011 · Cited by 224
Pang, Y., Dong, J., & Thomas, P. (2012) · Endocrinology · doi:10.1210/en.2012-1772 · Cited by 228
Role of aldo-keto reductase family 1 (AKR1) enzymes in human steroid metabolism
Rižner, T. L., & Penning, T. M. (2014) · Steroids · doi:10.1016/j.steroids.2013.10.012 · Cited by 217
Glutamate- and GABA-based CNS therapeutics
Foster, A. C., & Kemp, J. A. (2005) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2005.11.005 · Cited by 214
Kapogiannis, D., Reiter, D. A., Willette, A. A., & Mattson, M. P. (2013) · NeuroImage · doi:10.1016/j.neuroimage.2012.09.029 · Cited by 211
Sieghart, W., & Savić, M. M. (2018) · Pharmacological Reviews · doi:10.1124/pr.117.014449 · Cited by 210
Neurosteroid regulation of central nervous system development
Mellon, S. H. (2007) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2007.04.011 · Cited by 209
Neurosteroid modulation of synaptic and extrasynaptic GABAA receptors
Herd, M. B., Belelli, D., & Lambert, J. J. (2007) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2007.03.007 · Cited by 206
Self-citationWang, M., Wang, X., Zhao, L., Ma, W., Rodríguez, I. R., Fariss, R. N., & Wong, W. T. (2014) · Journal of Neuroscience · doi:10.1523/jneurosci.3153-13.2014 · Cited by 211
Neurosteroids as modulators of neurogenesis and neuronal survival
Charalampopoulos, I., Remboutsika, E., Margioris, A. N., & Gravanis, A. (2008) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2008.07.004 · Cited by 205
Tritsch, N. X., Oh, W., Gu, C., & Sabatini, B. L. (2014) · eLife · doi:10.7554/elife.01936 · Cited by 213
GABAA receptors and plasticity of inhibitory neurotransmission in the central nervous system
Fritschy, J., & Panzanelli, P. (2014) · European Journal of Neuroscience · doi:10.1111/ejn.12534 · Cited by 212
Steroids and glial cell function
García‐Segura, L. M., & Melcangi, R. C. (2006) · Glia · doi:10.1002/glia.20404 · Cited by 204
Neurosteroids and GABA-A Receptor Function
Wang, M. (2011) · Frontiers in Endocrinology · doi:10.3389/fendo.2011.00044 · Cited by 207
Neurosteroids, stress and depression: Potential therapeutic opportunities
Zorumski, C. F., Paul, S. M., Izumi, Y., Covey, D. F., & Mennerick, S. J. (2012) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2012.10.005 · Cited by 204
Soluble epoxide hydrolase and epoxyeicosatrienoic acids modulate two distinct analgesic pathways
İnceoğlu, B., Jinks, S. L., Ulu, A., Hegedus, C. M., Georgi, K., Schmelzer, K. R., Wagner, K. M., Jones, P. D., Morisseau, C. H. P., & Hammock, B. D. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0809765105 · Cited by 188
The major central endocannabinoid directly acts at GABA A receptors
Sigel, E., Baur, R., Rácz, I., Marazzi, J., Smart, T. G., Zimmer, A., & Gertsch, J. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1113444108 · Cited by 187
Neural mechanisms underlying changes in stress-sensitivity across the menstrual cycle
Ossewaarde, L., Hermans, E. J., van Wingen, G. A., Kooijman, S. C., Johansson, I.-M., Bäckström, T., & Fernández, G. (2010) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2009.08.011 · Cited by 185
A New Look at the 5?-Reductase Inhibitor Finasteride
Finn, D. A., Beadles-Bohling, A. S., Beckley, E. H., Ford, M. M., Gililland, K. R., Gorin-Meyer, R. E., & Wiren, K. M. (2006) · CNS Drug Reviews · doi:10.1111/j.1527-3458.2006.00053.x · Cited by 187
Neurosteroids: Endogenous allosteric modulators of GABAA receptors
Lambert, J. J., Cooper, M. A., Simmons, R. D. J., Weir, C. J., & Belelli, D. (2009) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2009.08.009 · Cited by 180
Self-citationCrystal structures of a GABAA-receptor chimera reveal new endogenous neurosteroid-binding sites.
Laverty, D., Thomas, P., Field, M., Andersen, O. J., Gold, M. G., Biggin, P. C., Gielen, M., & Smart, T. G. (2017) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.3477 · Cited by 179
Fragile X Syndrome: The GABAergic System and Circuit Dysfunction
Paluszkiewicz, S. M., Martin, B. S., & Huntsman, M. M. (2011) · Developmental Neuroscience · doi:10.1159/000329420 · Cited by 185
Etiologies underlying sex differences in autism spectrum disorders
Schaafsma, S. M., & Pfaff, D. W. (2014) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2014.03.006 · Cited by 178
The complexity of the GABAA receptor shapes unique pharmacological profiles
D’Hulst, C., Atack, J. R., & Kooy, R. F. (2009) · Drug Discovery Today · doi:10.1016/j.drudis.2009.06.009 · Cited by 178
Acute and chronic effects of ethanol on learning-related synaptic plasticity
Zorumski, C. F., Mennerick, S. J., & Izumi, Y. (2013) · Alcohol · doi:10.1016/j.alcohol.2013.09.045 · Cited by 177
Progress report on new antiepileptic drugs: A summary of the Twelfth Eilat Conference (EILAT XII)
Bialer, M., Johannessen, S. I., Levy, R. H., Perucca, E., Tomson, T., & White, H. S. (2015) · Epilepsy Research · doi:10.1016/j.eplepsyres.2015.01.001 · Cited by 174
The GABAergic system as a therapeutic target for Alzheimer's disease
Guzmán, B. C., Vinnakota, C., Govindpani, K., Waldvogel, H. J., Faull, R. L. M., & Kwakowsky, A. (2018) · Journal of Neurochemistry · doi:10.1111/jnc.14345 · Cited by 172
Porcu, P., Barron, A. M., Frye, C. A., Walf, A. A., Yang, S., He, X., Morrow, A. L., Panzica, G., & Melcangi, R. C. (2015) · Journal of Neuroendocrinology · doi:10.1111/jne.12351 · Cited by 186
Conserved site for neurosteroid modulation of GABAA receptors
Hosie, A. M., Clarke, L., da Silva, H., & Smart, T. G. (2008) · Neuropharmacology · doi:10.1016/j.neuropharm.2008.07.050 · Cited by 170
Borghese, C. M., Stórustovu, S. I., Ebert, B., Herd, M. B., Belelli, D., Lambert, J. J., Marshall, G. R., Wafford, K. A., & Harris, R. A. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.092452 · Cited by 170
Self-citationMonnet, F. P., & Maurice, T. (2006) · Journal of Pharmacological Sciences · doi:10.1254/jphs.cr0050032 · Cited by 167
Neurosteroids as regenerative agents in the brain: therapeutic implications
Brinton, R. D. (2013) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2013.31 · Cited by 169
Schumacher, M., Guennoun, R., Ghoumari, A. M., Massaad, C., Robert, F., El‐Etr, M., Akwa, Y., Rajkowski, K. M., & Baulieu, É.-É. (2007) · Endocrine Reviews · doi:10.1210/er.2006-0050 · Cited by 170
GABA Receptors: Pharmacological Potential and Pitfalls
Jembrek, M. J., & Vlainić, J. (2015) · Current Pharmaceutical Design · doi:10.2174/1381612821666150914121624 · Cited by 171
Mechanisms of neurosteroid interactions with GABAA receptors
Akk, G., Covey, D. F., Evers, A. S., Steinbach, J. H., Zorumski, C. F., & Mennerick, S. J. (2007) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2007.03.004 · Cited by 162
The Neurosteroid Allopregnanolone Is Reduced in Prefrontal Cortex in Alzheimer’s Disease
Marx, C. E., Trost, W. T., Shampine, L. J., Stevens, R. D., Hulette, C. M., Steffens, D. C., Ervin, J. F., Butterfield, M. I., Blazer, D. G., Massing, M. W., et al. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.06.017 · Cited by 165
Wafford, K. A., van Niel, M. B., Ma, Q., Horridge, E., Herd, M. B., Peden, D. R., Belelli, D., & Lambert, J. J. (2008) · Neuropharmacology · doi:10.1016/j.neuropharm.2008.08.004 · Cited by 156
Self-citationShaping of the Female Human Brain by Sex Hormones: A Review
Rehbein, E., Hornung, J., Poromaa, I. S., & Derntl, B. (2020) · Neuroendocrinology · doi:10.1159/000507083 · Cited by 159
GABAA Receptors in Normal Development and Seizures: Friends or Foes?
Galanopoulou, A. (2008) · Current Neuropharmacology · doi:10.2174/157015908783769653 · Cited by 156
Pinna, G., Costa, E., & Guidotti, A. (2009) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2008.12.006 · Cited by 156
Neurosteroid Access to the GABAAReceptor
Akk, G., Shu, H., Wang, C., Steinbach, J. H., Zorumski, C. F., Covey, D. F., & Mennerick, S. J. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.4173-05.2005 · Cited by 156
GABA A Receptors and the Diversity in their Structure and Pharmacology
Chua, H. C., & Chebib, M. (2017) · Advances in pharmacology · doi:10.1016/bs.apha.2017.03.003 · Cited by 154
Gunn, B. G., Cunningham, L., Cooper, M. A., Corteen, N. L., Seifi, M., Swinny, J. D., Lambert, J. J., & Belelli, D. (2013) · The Journal of Neuroscience · doi:10.1523/jneurosci.1337-13.2013 · Cited by 151
Self-citationLuchetti, S., Huitinga, I., & Swaab, D. F. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.04.010 · Cited by 164
Crowley, T., Cryan, J. F., Downer, E. J., & O’Leary, O. F. (2016) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2016.02.001 · Cited by 150
Gaignard, P., Savouroux, S., Liere, P., Pianos, A., Thérond, P., Schumacher, M., Slama, A., & Guennoun, R. (2015) · Endocrinology · doi:10.1210/en.2014-1913 · Cited by 150
GABAA receptor-acting neurosteroids: a role in the development and regulation of the stress response
Gunn, B. G., Cunningham, L., Mitchell, S. G., Swinny, J. D., Lambert, J. J., & Belelli, D. (2015) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2014.06.001 · Cited by 149
Self-citationGABAA receptors: structure and function in the basal ganglia
Goetz, T., Arslan, A., Wisden, W., & Wulff, P. (2007) · Progress in brain research · doi:10.1016/s0079-6123(06)60003-4 · Cited by 149
Chuang, S.-H., & Reddy, D. S. (2017) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.117.244673 · Cited by 149
GABAergic Synaptic Transmission
Draguhn, A., & Hartmann, K. (2006) · Advances in molecular and cell biology · doi:10.1016/s1569-2558(06)38009-5 · Cited by 149
Quilichini, P., Chiron, C., Ben‐Ari, Y., & GOZLAN, H. (2006) · Epilepsia · doi:10.1111/j.1528-1167.2006.00497.x · Cited by 147
Nohria, V., & Giller, E. L. (2007) · Neurotherapeutics · doi:10.1016/j.nurt.2006.11.003 · Cited by 145
Role of GABAAreceptors in the physiology and pharmacology of sleep
Winsky‐Sommerer, R. (2009) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2009.06716.x · Cited by 147
Metadata
- Authors
- Belelli, D., & Lambert, J. J.
- Affiliations
- University of Dundee (GB)
- Corresponding author
- Lambert, Jeremy J.
- Venue
- Nature reviews. Neuroscience
- Published
- 2005-06-15
- Volume
- 6
- Issue
- 7
- Pages
- 565-575
- ISSN
- 1471-003X (ISSN-L)
- 1471-0048
- OpenAlex
- W2070510853
- Semantic Scholar
- 1e15686792dd96994a0bd1337b50f1e4448b7965
- Cited by
- 1,159
- References
- 123
- Citations by year
- 2026: 32 · 2025: 40 · 2024: 45 · 2023: 51 · 2022: 49 · 2021: 52 · 2020: 53 · 2019: 49 · 2018: 54 · 2017: 43 · 2016: 57 · 2015: 57 · 2014: 71 · 2013: 64 · 2012: 55
- FWCI
- 5.43
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature reviews. Neuroscience (publishedVersion)
- PubMed (publishedVersion)
- Discovery Research Portal (University of Dundee) (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacological Receptor Mechanisms and Effects
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
- Keywords
- neurosteroids, GABAA receptor, pregnane steroids, non-genomic steroid action, synaptic inhibition, anxiolytic effects, anticonvulsant activity, anesthesia, psychoactive substances
- MeSH terms
- Animals, Brain, Humans, Models, Biological, Neural Inhibition, Synaptic Transmission, Pregnanes, Receptors, GABA-A, Antipsychotic Agents, Mood Disorders
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review